Here are five notes:
1. The firm gave AmSurg a $90 price target.
2. Cantor Fitzgerald has a “buy” rating on AmSurg shares.
3. The price target indicates a 43.75 percent potential upside for AmSurg shares.
4. The market cap. is $3.37 billion.
5. AmSurg’s P/E ratio is 18.58.
More articles on surgery centers:
Carle submits CON application to relocate surgery center — 5 takeaways
How physicians and hospitals can benefit from joint ventures
Independent vs. hospital-associated ASCs: Mutually assured destruction or an uneasy truce?
